Hepatocellular carcinoma and direct-acting antivirals: A never ending story?

被引：4
作者：
Calvaruso, Vincenza [1 ]
Craxi, Antonio [1 ]
机构：
[1] Univ Palermo, DIBIMIS, Gastroenterol & Epatol, Palermo, Italy
来源：
LIVER INTERNATIONAL | 2017年 / 37卷 / 06期
关键词：
C VIRUS-INFECTION; SUSTAINED VIROLOGICAL RESPONSE; CHRONIC HEPATITIS-C; GENERAL-POPULATION; CIRRHOTIC-PATIENTS; RISK; ERADICATION; RECURRENCE; HCC; THERAPY;
D O I：
10.1111/liv.13421
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：812 / 814
页数：3
相关论文
共 17 条
  • [1] Alberti A, 2017, LIVER INT
  • [2] [Anonymous], LIVER INT
  • [3] Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
    不详
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 734 - 740
  • [4] Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population
    Bruno, Savino
    Di Marco, Vito
    Iavarone, Massimo
    Roffi, Luigi
    Crosignani, Andrea
    Calvaruso, Vincenza
    Aghemo, Alessio
    Cabibbo, Giuseppe
    Vigano, Mauro
    Boccaccio, Vincenzo
    Craxi, Antonio
    Colombo, Massimo
    Maisonneuve, Patrick
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 (06) : 1217 - 1223
  • [5] Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
    Cabibbo, G.
    Cacciola, I.
    Cannavo, M. R.
    Madonia, S.
    Calvaruso, V.
    Petta, S.
    Distefano, M.
    Larocca, L.
    Prestileo, T.
    Tine, F.
    Digiacomo, A.
    Bertino, G.
    Giannitrapani, L.
    Benanti, F.
    Davi, A.
    Volpes, R.
    Scalisi, I.
    Iacobello, C.
    Mazzola, G.
    Cartabellotta, F.
    Guarneri, L.
    Portelli, V.
    Averna, A.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    Camma, C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E59 - E59
  • [6] Calvaruso V, 2017, J HEPATOL
  • [7] Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
    Cheung, Michelle C. M.
    Walker, Alex J.
    Hudson, Benjamin E.
    Verma, Suman
    McLauchlan, John
    Mutimer, David J.
    Brown, Ashley
    Gelson, William T. H.
    MacDonald, Douglas C.
    Agarwal, Kosh
    Foster, Graham R.
    Irving, William L.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 741 - 747
  • [8] Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
    Di Marco, Vito
    Calvaruso, Vincenza
    Ferraro, Donatella
    Bavetta, Maria Grazia
    Cabibbo, Giuseppe
    Conte, Elisabetta
    Camma, Calogero
    Grimaudo, Stefania
    Pipitone, Rosaria Maria
    Simone, Fabio
    Peralta, Sergio
    Arini, Andrea
    Craxi, Antonio
    [J]. GASTROENTEROLOGY, 2016, 151 (01) : 130 - +
  • [9] Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
    Fattovich, G
    Stroffolini, T
    Zagni, I
    Donato, F
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S35 - S50
  • [10] Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment
    Kozbial, Karin
    Moser, Stephan
    Schwarzer, Remy
    Laferl, Hermann
    Al-Zoairy, Ramona
    Stauber, Rudolf
    Staettermayer, Albert F.
    Beinhardt, Sandra
    Graziadei, Ivo
    Freissmuth, Clarissa
    Maieron, Andreas
    Gschwantler, Michael
    Strasser, Michael
    Peck-Radosalvjevic, Markus
    Trauner, Michael
    Hofer, Harald
    Ferenci, Peter
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 856 - 858
12